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The  deleterious  effects  of  Right  ventricular  (RV)  pacing  on  development  of  ventricular 
dyssynchrony leading to heart failure, genesis of atrial fibrillation and consequent increased 
mortality have been repeatedly demonstrated in numerous pacing studies. Trials with dual 
chamber pacemakers and defibrillators did not succeed in negating these effects, raising the 
question if it was RV pacing per se or RV apical pacing that was the culprit. Innovations in 
algorithms to reduce RV pacing were simultaneously  supplemented  by investigation  into 
alternative sites of pacing to counter these undesirable outcomes. These included pacing of 
the His bundle, right ventricular outflow tract (RVOT), mid and apical septum. Dictated by 
the ability  to achieve satisfactory lead stability  and thresholds,  the search has practically 
narrowed to septal pacing. Physiologically septal pacing results in earlier depolarization of 
the septum and a closer conduction sequence to normal. This would be expected to reduce 
LV activation time,  prevent dyssynchrony and preserve LV function.  RVOT remains  the 
most  investigated  non-  apical  pacing  site,  though  other  septal  sites  theoretically  can  be 
expected  to  result  in  a  similar  benefit  by  achieving  a  narrow QRS and a  physiological 
ventricular  activation.                                             
Studies in the real world however found that the theoretical expectations of septal pacing did 
not  automatically  translate  into  consistent  clinical  benefits.  Several  hypotheses  can  be 
offered to explain this discrepancy. First pertains to the complexity of the RVOT anatomy 
which encompasses septal, anterior and free wall segments. Positioning the ventricular lead 
in each of these areas may not be in operator’s control and more importantly all these areas 
cannot be assumed to be similar in terms of pacing outcomes. Higher septal areas may be 
closer to aorta than LV and pacing infundibular region may result in higher thresholds. In 
fact it was found that only a third of RVOT pacing positions truly achieved a septal position 
using the conventional fluoroscopic views. Secondly, even when the lead is truly septal, in 
practice it is not always feasible to achieve a precise pacing target in the septum. Also, there 
exists no concrete data on the differential outcomes of different septal positions from high to 
low, making it difficult to advocate the superiority of one over the other. Thus, there exists 
considerable expected heterogeneity with respect to septal pacing. The third aspect concerns 
the imaging and electrocardiographic guidance of the septal positioning of the pacing lead. 
Typically  three fluoroscopic views are recommended-  the AP, LAO and RAO to ensure 
septal positioning and avoiding the coronary sinus ostium. Yet one should appreciate that 
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conventional  fluoroscopic guidance for achieving targeted lead positions is not infallible. 
Surface ECG demonstrates a narrow QRS complex when paced from any of the areas of 
septum and a negative QRS in lead I, is indicative of anterior rather than septal position. This 
fact has however not been validated by clinical studies and there is no uniform agreement 
even when 3 dimensional electroanatomical mapping studies are used. Lastly, there is a lack 
of clarity on the duration of time required to perceive the beneficial effects of septal pacing 
and varied follow up times in studies involving septal pacing contribute to conflicting results.
It  follows  that  reliable  comparative  assessment  of  implant  parameters,  procedural 
complications, cardiovascular and mortality endpoints amongst different septal areas will be 
possible  only if  there is  standardization of lead position in the septum. In addition,  it  is 
necessary to evolve an objective imaging or ECG parameter to authenticate the lead position. 
It  is  envisaged  that  studies  with  targeted  septal  pacing  locations  will  provide  the  much 
awaited  clinical  evidence,  applicable  to  a  broad  population.  Three  such  studies  were 
designed, with specified lead locations– Protect pace (High septum), RASP (RV Inflow), and 
Optimize RV (Mid septum), the last of which was abandoned. The ongoing trials on non-
apical pacing by protocol have unambiguous lead positions, with a fair follow up time and it 
is expected that their results will provide further insight. A more important fact that such 
studies are expected to unravel is, if  it is a worthwhile effort for the operators to go through 
the learning curve and challenges to  master the technique of targeted septal pacing.
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